<DOC>
	<DOC>NCT02538692</DOC>
	<brief_summary>The purpose of this study is to test the efficacy and safety of a traditional Chinese medication Tong-Xie-Yao-Fang for patients with diarrhea-predominant irritable bowel Syndrome (IBS-D).</brief_summary>
	<brief_title>Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome</brief_title>
	<detailed_description>Participants: The sample size of this trial is 118, to test an odds ratio of 3.5 at a significance of 0.05 and power of 0.8. Intervention: Tong-Xie-Yao-Fang versus placebo Data collection: Standard operation procedure will be developed for how to interviewing the participants, how to use the IBS diary, how to enter the data into the electronic case report forms.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Being diagnosed as IBS according to the Rome III criteria; Diarrhea was present for at least 75% of the time; With a TCM differentiation as "liver stagnation and spleen defficiency" Had a colonoscopy within a year to rule out other bowel diseases. Organic gastrointestinal disease, such as colorectal cancer, inflammatory bowel disease, advanced colonic polyp; Had gastrointestinal surgery within a year; Used durgs that affect gastrointestinal motility; Had psychological disorder; Serious disease in other system, which may bias the outcome measures.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>